Earticle

현재 위치 Home

소화기관용약제 처방지침이 의사의 소화기관용약 처방률에 미치는 효과분석
The Impacts of Guideline for Digestives on Physicians' Prescription of GI medication

첫 페이지 보기
  • 발행기관
    한국임상약학회 바로가기
  • 간행물
    한국임상약학회지 KCI 등재 바로가기
  • 통권
    제18권 제2호 (2008.12)바로가기
  • 페이지
    pp.124-131
  • 저자
    김동숙, 박춘선, 장선미
  • 언어
    한국어(KOR)
  • URL
    https://www.earticle.net/Article/A100765

※ 기관로그인 시 무료 이용이 가능합니다.

4,000원

원문정보

초록

영어
The impacts of guideline for digestives on physicians' prescription of GI medication Clinical practice guidelines pro-vide benefits to physicians, patients, and researchers. It also helps doctors to make decisions in medical services. Inmany countries, practice guidelines lead to activities of quality improvement and are developed using evidence basedmethods. This research was to assess the impacts of Korean Medical Association's guideline for digestives on thechange of physicians' behavior. This study was progressed as one-group pre-test post-test quasi-experimental designusing health insurance claims data. The unit of analysis was institution. Data was analyzed using paired t-test forchange of prescription rate before and after the distribution of practice guidelines. And the multiple regression analy-sis was performed to examine the independent impact of the guideline on the prescribing rate of GI medication. Pre-scription rates of GI medication per claim by medical institution increased significantly, 1.98%point(from 50.27% to52.25%) and multivariate regression analysis showed significant increase in the prescription rate of GI medicationafter the distribution of guideline(p<0.001). In conclusion, the distribution of guideline for digestive might not havethe effects on the change in provider's behavior. Furthermore, to activate the use of practice guideline, it would benecessary to educate the contents to physicians as well as to develop practice guideline.

목차

abstract
 연구방법
 연구결과
 고찰 및 결론
 참고문헌

키워드

practice guideline physicians prescriptions

저자

  • 김동숙 [ DongSook Kim | 건강보험심사평가원 심사평가연구실(Health Insurance Review and Assessment Service, Seoul, Korea) ]
  • 박춘선 [ ChoonSeon Park | 건강보험심사평가원 심사평가연구실(Health Insurance Review and Assessment Service, Seoul, Korea) ]
  • 장선미 [ SunMee Jang | 건강보험심사평가원 심사평가연구실(Health Insurance Review and Assessment Service, Seoul, Korea) ] Correspondence

참고문헌

자료제공 : 네이버학술정보

간행물 정보

발행기관

  • 발행기관명
    한국임상약학회 [Korean College of Clinical Pharmacy]
  • 설립연도
    1
  • 분야
    의약학>약학
  • 소개
    합리적 약물치료(rational pharmacotherapy)의 보장 및 증진을 궁극목적으로 하며 이를 달성하기 위해 임상약학의 발전과 회원 상호간의 친목을 도모한다.

간행물

  • 간행물명
    한국임상약학회지 [Korean Journal of Clinical Pharmacy]
  • 간기
    계간
  • pISSN
    1226-6051
  • 수록기간
    1991~2026
  • 등재여부
    KCI 등재
  • 십진분류
    KDC 518 DDC 615

이 권호 내 다른 논문 / 한국임상약학회지 제18권 제2호

    피인용수 : 0(자료제공 : 네이버학술정보)

    함께 이용한 논문 이 논문을 다운로드한 분들이 이용한 다른 논문입니다.

      페이지 저장